[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345792-105":59,"doc-detail-345792-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","impact-of-fertility-preservation-on-quality-of-life-recurrence-and-reproductive-success-in-young-female-cancer-survivors-a-korean-prospective-multicentre-cohort-study-protocol-life-repro","Impact of fertility preservation on quality of life, recurrence and reproductive success in young female cancer survivors - a Korean prospective multicentre cohort study protocol (LIFE-Repro)","","Gynaecological cancers increasingly affect women of reproductive age, yet the long-term impact of fertility-sparing treatments on survivorship remains insufficiently studied, particularly regarding sexual function, quality of life (QoL), and reproductive outcomes. LIFE-Repro is a prospective multicentre cohort evaluating young female cancer survivors. Between 2023 and 2027, eleven Korean tertiary hospitals recruit 200 patients (≤45 years) undergoing baseline and 6-month follow-ups, using a study-developed mobile app to collect patient-reported outcomes. Primary outcome is post-treatment sexual dysfunction via the Female Sexual Function Index–Korean version, with secondary endpoints including QoL trajectories, recurrence, survival, pregnancy, live birth, and premature menopause; ethics and dissemination are also detailed.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/impact-of-fertility-preservation-on-quality-of-life-recurrence-and-reproductive-success-in-young-female-cancer-survivors-a-korean-prospective-multicentre-cohort-study-protocol-life-repro/345792/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/impact-of-fertility-preservation-on-quality-of-life-recurrence-and-reproductive-success-in-young-female-cancer-survivors-a-korean-prospective-multicentre-cohort-study-protocol-life-repro/345792.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the primary endpoint of the LIFE-Repro study?","Question",{"text":112,"@type":113},"The primary endpoint is the incidence of post-treatment sexual dysfunction measured by the Female Sexual Function Index–Korean version.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How often will participants be followed up and how are outcomes collected?",{"text":117,"@type":113},"Participants will have prospective follow-ups every 6 months. Patient-reported outcomes on sexual function, QoL, and health status will be collected using a mobile application developed by the research team.",{"name":119,"@type":110,"acceptedAnswer":120},"What secondary outcomes are included in the study?",{"text":121,"@type":113},"Secondary endpoints include longitudinal QoL changes, cancer recurrence, survival, pregnancy rates, live birth rates, and premature menopause.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345792,1790504912,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Open access Protocol  \n Impact of fertility preservation on  \nquality of life, recurrence and reproductive success in young female cancer survivors: a Korean prospective multicentre cohort study protocol (LIFERepro)  \nHyun-Woong Cho  ,1 Se Ik Kim,2 Jeong-Yeol Park  ,1 Jung Bok Lee,1 Chel Hun Choi,3 Jung-Yun Lee,4 Bo Hyon Yun  ,4 Myong Cheol Lim,5 Sung-Jong Lee,6 Kyung-Jin Min,7 Ji Geun Yoo,8 Dong Hoon Suh  ,9 Yunjung Choi,10 Jae-Weon Kim2  \nTo cite: Cho H-W, Kim SI, Park J-Y, et al. Impact of fertility preservation on quality of life, recurrence and reproductive success in young female cancer survivors: a Korean prospective multicentre cohort study protocol (LIFE-Repro) . BMJ Open 2026;16:e118696 . doi:10 . 1136/ bmjopen-2026-118696  \n► Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[bmjopen-2026-118696](bmjopen-2026-118696)) .  \nReceived 23 February 2026 Accepted 15 May 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Jae-Weon Kim; [kjwksh@snu.ac.kr](kjwksh@snu.ac.kr)  \nABSTRACT  \nIntroduction Gynaecological cancers increasingly affect women of reproductive age, necessitating fertilitysparing treatments that balance oncological safety with reproductive potential. However, the long-term impact of these treatments on survivorship—specifically regarding sexual function, quality of life (QoL) and reproductive outcomes—remains understudied. LIFE-Repro is a prospective multicentre cohort study designed to evaluate these impacts in young female cancer survivors.  \nMethods and analysis Between 2023 and 2027, eleven tertiary referral hospitals in Korea will recruit 200 patients aged ≤45 years with gynaecological cancers who have undergone fertility-sparing treatment. Participants will undergo baseline assessments followed by prospective follow-ups every 6 months. At each visit, patient-reported outcomes assessing sexual function, QoL and health status will be collected using a mobile application developed by the research team. The primary endpoint is the incidence of post-treatment sexual dysfunction measured by the Female Sexual Function Index–Korean version. Secondary endpoints include longitudinal changes in QoL, cancer recurrence, survival, pregnancy rates, live birth rates and premature menopause.  \nEthics and dissemination The study protocol was approved by the Institutional Review Board of Korea University Guro Hospital (2024GR0484) . Results will be disseminated through peer-reviewed journals and conference presentations.  \nTrial registration number KCT0009578.  \nINTRODUCTION  \nGynaecological cancers, encompassing malignancies of the ovary, endometrium, cervix and other reproductive organs, pose significant health risks to women worldwide. Among those affected, a substantial proportion are of reproductive age, for whom the implications  \nof treatment extend beyond survival to encompass fertility preservation and quality of life. According to national cancer statistics of Korea, although the annual per cent changes (APCs) for overall patients with gynaecological cancer have been decreasing, the APCs for females younger than 30 years of age have been increasing.1 Fertility-sparing treatments, which aim to conserve reproductive potential while effectively managing cancer, have emerged as pivotal options for young women diagnosed with early-stage gynaecological malignancies. Despite the growing adoption of fertility-sparing treatments, there remains a critical need to understand the long-term outcomes and survivorship experiences of  \nwomen undergoing these procedures.  \nAccording to the American Cancer Society guidelines, fertility preservation treatment is recommended for","cbCaikW5xkLC1B6p","https://ap.wps.com/l/cbCaikW5xkLC1B6p","pdf",419679,"English","# ABSTRACT\n## Introduction\n## Methods and analysis\n## Ethics and dissemination\n# INTRODUCTION\n# STRENGTHS AND LIMITATIONS OF THIS STUDY","[{\"question\":\"What is the primary endpoint of the LIFE-Repro study?\",\"answer\":\"The primary endpoint is the incidence of post-treatment sexual dysfunction measured by the Female Sexual Function Index–Korean version.\"},{\"question\":\"How often will participants be followed up and how are outcomes collected?\",\"answer\":\"Participants will have prospective follow-ups every 6 months. Patient-reported outcomes on sexual function, QoL, and health status will be collected using a mobile application developed by the research team.\"},{\"question\":\"What secondary outcomes are included in the study?\",\"answer\":\"Secondary endpoints include longitudinal QoL changes, cancer recurrence, survival, pregnancy rates, live birth rates, and premature menopause.\"}]","Impact of fertility preservation on quality of life, recurrence and reproductive success in young female cancer survivors - a Korean prospective multicentre cohort study protocol (LIFE-Repro) | PDF",1790058895,13,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86f37b1ede429421133379b5999b3360.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f15309a25cb7cb4bea6ad75debeee21f.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0cb3a85c83d3ce881dc382578a1e51d3.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdaf1c3336c1e2df7969d5b59cae09cd.webp",980,1306]